The British journal of surgery
-
Treatment of patients with Crohn's disease has evolved in recent decades, with increasing use of immunomodulatory medication since 1990 and biologicals since 1998. In parallel, there has been increased use of active disease monitoring. To what extent these changes have influenced the incidence of primary and repeat surgical resection remains debated. ⋯ The 5-year rate of surgical intervention for Crohn's disease has decreased significantly, but the rate of repeat surgery has remained stable despite the introduction of biological therapy.
-
Letter Randomized Controlled Trial
Pulmonary Metastasectomy in Colorectal Cancer: the PulMiCC randomised controlled trial.
-
Letter Multicenter Study
COVID-19: No benefit of chest inclusion in acute abdomen CT.